We are Sorry, This Page doesn't Exist
Alligator Bioscience AB: Year-end Report January-December 2020
STOCKHOLM, Feb. 26, 2021 /PRNewswire/ -- "Safety data has been presented from the ongoing Phase I study with ATOR-1017 in patients with metastatic cancer. The results show a promising safety profile w.....»»
Against backdrop of shelter-in-place, Peninsula biotech asks FDA to approve prostate cancer drug
Filing thousands of pages of data electronically from remote locations as employees sheltered in place against Covid-19, Myovant Sciences asked regulators Tuesday to quickly approve its once-a-day pill against prostate cancer. The Brisbane company a.....»»
The Daily Biotech Pulse: Xeris Jumps On Positive Data, Mixed Results For Merck"s Keytruda-Chemo Combo In Lung Cancer, Intra-Cellular Announces Offering
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biot.....»»
Fate Therapeutics" stock rises on early-stage cancer drug data
Shares of Fate Therapeutics gained 37% after it shared promising data from one clinical and one preclinical study for its experimental cancer immunotherapy treatments. The company is testing two therapies, FT516 and FT500, in.....»»
The Daily Biotech Pulse: Eli Lily Revenues Trail Estimates, Moderna Gets Fast Track Designation, MacroGenics" Lukewarm Breast Cancer Data
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Oct. 22) read more.....»»
The Daily Biotech Pulse: Eli Lily Revenues Trail Estimates, Moderna Gets Fast Track Designation, MacroGenics" Lukewarm Breast Cancer Data
Here's a roundup of top developments in the biot.....»»
Nektar breast cancer data "promising," warrants more study, says Piper Jaffray
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Cancer-Fighting Stocks & ETF: What You Need to Know
Many biotech stocks soared after they presented very promising cancer treatment results at the ASCO conference Want the latest recommendations from Zacks Investment Resear.....»»
Genocea Biosciences shares rocket 101% after biotech announces positive data from early-stage trial of cancer vaccine
Shares of Genocea Biosciences Inc. su.....»»
Biotech News Recap: Biogen Reports Promising Data In ALS, Still Facing Several Challenges
Biotech News Recap: Biogen Reports Promising Data In ALS, Still Facing Several Challenges.....»»
Moleculin Biotech reports precilinical data in pancreatic cancer candidates
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Dynavax shares rise 14% on promising cancer conference data
Dynavax Technologies Corp. shares rose 14% in premarket trade Monday after the company released promising data in conjunction with.....»»
Biotech Analysis Central Pharma News: Allergan And Richter"s Success, Sellas Life Sciences" Breast Cancer Data, AbbVie"s Patent Boost
Biotech Analysis Central Pharma News: Allergan And Richter"s Success, Sellas Life Sciences" Breast Cancer Data, AbbVie"s Patent Boost.....»»
Brainstorm Health: Facebook Hospital Data, Incyte Stock, Yescarta Price
Brainstorm Health Daily: April 6, 2018 Hello and happy Friday, readers! This is Sy. Shares of biotech Incyte tumbled following a clinical trial setback for one of the company’s marquee experimental cancer.....»»
Clovis stock rises 8% on promising results in prostate cancer trial
Clovis Oncology Inc. shares rose nearly 8% in Friday premarket trade after the company released initial data from an ongoing prostate cancer trial showing that, in 25 patients, 44% showed a reducti.....»»
AstraZeneca"s Imfinzi/Chemo Combo Doubles Overall Survival In Biliary Tract Cancer Patients At 3 Years, Data Shows
AstraZeneca's updated data from TOPAZ-1 Phase 3 trial of Imfinzi (durvalumab) in advanced biliary tract cancer patients. Unveiling long-term survival benefits and significant overall survival improvement. read more.....»»
Enliven Therapeutics Shares First Look At Safety, Clinical Activity Of Lead Program
Enliven Therapeutics' Phase 1 trial results for ELVN-001 in chronic myeloid leukemia (CML) patients. Explore the promising safety and efficacy data. read more.....»»
The Week Ahead In Biotech (May 23-29): Eton, Lantheus FDA Decisions, Adcom Test For Provention, Chiasma Data Presentation
Biotech stocks advanced in the week ended May 21, as risk aversion forced traders to buy into defensives. As earnings news flow tapered, stocks took cues from clinical readouts. read more.....»»
Sutro Biopharma ovarian cancer data "impressive," says Piper Sandler
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»